AltruBio

ActiveBorn in Taiwan, based elsewhere

Immune checkpoint enhancers · Taiwan

HQFormerly AbGenomics, founded in Taipei; now run from San Francisco, with research in Taipei

Last roundSeries B · May 2024

Country of originTaiwanBorn here, based elsewhere

BasedFormerly AbGenomics, founded in Taipei; now run from San Francisco, with research in Taipei

Born in Taiwan, based elsewhere

AltruBio is listed by the Taiwan ranking as a company founded by Taiwan-linked founders but headquartered abroad: it is not ranked in Taiwan. Formerly AbGenomics, founded in Taipei; now run from San Francisco, with research in Taipei.

Funding history

Date	Round	Amount	Type	Investors
May 2024	Series B	up to USD 225M	—	BVF Partners, RA Capital, Cormorant, Soleus Capital

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Taiwan · all sectors	Born here, based elsewhere	—	Edition 0 · October 2026	21 Jan 2027

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of AltruBio as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is AltruBio worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back AltruBio whether or not it has agreed: your intention joins the pool on AltruBio, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back AltruBio Or back biotech in Taiwan

Pool on AltruBioBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run AltruBio?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Taiwan

Full Taiwan ranking →

Elixiron#6Biotech › immunotherapyHundreds of M$Syncell#15Biotech › spatial proteomics toolsTens of M$ProLogium#1Energy › solid-state batteriesUnicorn KKday#2Travel › activities and experiencesHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.